MedTrace Logo

Study to Assess the Efficacy of Intralesional Corticosteroid on the Treatment of Frontal Fibrosing Alopecia

NCT02467101 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2015-06-09

No results posted yet for this study

Summary

The purpose of this study is to determine the efficacy of treatment with intralesional injection of corticosteroids on the treatment of Frontal Fibrosing Alopecia (compared with placebo), between three months, six months and baseline.

Conditions

  • Frontal Fibrosing Alopecia

Interventions

OTHER

Corticosteroid/Saline

Corticosteroid/Saline Two groups were defined: group A and group B. * Group A receives treatment with intralesional triamcinolone acetonide on the right half-head and placebo on the left half-head * Group B receives administration of intralesional triamcinolone acetonide on left half-head and placebo on the right half-head. Same patient will be injected with intralesional triamcinolone acetonide and a saline solution. Each patient will be injected on half-head.

Sponsors & Collaborators

  • Universitat Internacional de Catalunya

    collaborator OTHER

  • Rubina Alves

    lead OTHER

Principal Investigators

  • Rubina Alves, M.D. · Universitat Internacional Catalunya

  • Juan Antonio Moreno, M.D. · Universitat Internacional Catalunya

  • Ramon Grimalt, M.D.; PhD · Universitat Internacional Catalunya

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
TRIPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02467101 on ClinicalTrials.gov